vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Verisign (VRSN). Click either name above to swap in a different company.

Enovis CORP is the larger business by last-quarter revenue ($589.2M vs $425.3M, roughly 1.4× Verisign). Verisign runs the higher net margin — 48.5% vs -1.4%, a 49.9% gap on every dollar of revenue. On growth, Verisign posted the faster year-over-year revenue change (7.6% vs 5.4%). Over the past eight quarters, Enovis CORP's revenue compounded faster (5.9% CAGR vs 5.2%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

ENOV vs VRSN — Head-to-Head

Bigger by revenue
ENOV
ENOV
1.4× larger
ENOV
$589.2M
$425.3M
VRSN
Growing faster (revenue YoY)
VRSN
VRSN
+2.1% gap
VRSN
7.6%
5.4%
ENOV
Higher net margin
VRSN
VRSN
49.9% more per $
VRSN
48.5%
-1.4%
ENOV
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
5.9%
5.2%
VRSN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ENOV
ENOV
VRSN
VRSN
Revenue
$589.2M
$425.3M
Net Profit
$-8.4M
$206.2M
Gross Margin
62.0%
88.5%
Operating Margin
67.0%
Net Margin
-1.4%
48.5%
Revenue YoY
5.4%
7.6%
Net Profit YoY
7.7%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
VRSN
VRSN
Q1 26
$589.2M
Q4 25
$548.9M
$425.3M
Q3 25
$564.5M
$419.1M
Q2 25
$558.8M
$409.9M
Q1 25
$402.3M
Q4 24
$561.0M
$395.4M
Q3 24
$505.2M
$390.6M
Q2 24
$525.2M
$387.1M
Net Profit
ENOV
ENOV
VRSN
VRSN
Q1 26
$-8.4M
Q4 25
$-571.1M
$206.2M
Q3 25
$-36.7M
$212.8M
Q2 25
$-56.0M
$207.4M
Q1 25
$199.3M
Q4 24
$-703.2M
$191.5M
Q3 24
$-31.5M
$201.3M
Q2 24
$-18.6M
$198.8M
Gross Margin
ENOV
ENOV
VRSN
VRSN
Q1 26
62.0%
Q4 25
59.9%
88.5%
Q3 25
59.3%
88.4%
Q2 25
59.5%
88.0%
Q1 25
87.7%
Q4 24
54.8%
87.8%
Q3 24
56.7%
88.0%
Q2 24
55.0%
87.8%
Operating Margin
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
-101.7%
67.0%
Q3 25
-3.0%
67.8%
Q2 25
-8.4%
68.5%
Q1 25
67.4%
Q4 24
-118.5%
66.7%
Q3 24
-6.3%
68.9%
Q2 24
-8.4%
68.8%
Net Margin
ENOV
ENOV
VRSN
VRSN
Q1 26
-1.4%
Q4 25
-104.1%
48.5%
Q3 25
-6.5%
50.8%
Q2 25
-10.0%
50.6%
Q1 25
49.5%
Q4 24
-125.4%
48.4%
Q3 24
-6.2%
51.5%
Q2 24
-3.5%
51.4%
EPS (diluted)
ENOV
ENOV
VRSN
VRSN
Q1 26
$-0.15
Q4 25
$-9.99
Q3 25
$-0.64
Q2 25
$-0.98
Q1 25
Q4 24
$-12.69
Q3 24
$-0.58
Q2 24
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$33.1M
$580.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$1.5B
$-2.2B
Total Assets
$3.8B
$1.3B
Debt / EquityLower = less leverage
0.90×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
VRSN
VRSN
Q1 26
$33.1M
Q4 25
$33.6M
$580.5M
Q3 25
$44.1M
$617.7M
Q2 25
$38.5M
$593.8M
Q1 25
$648.5M
Q4 24
$48.2M
$599.9M
Q3 24
$35.4M
$644.9M
Q2 24
$35.0M
$689.9M
Total Debt
ENOV
ENOV
VRSN
VRSN
Q1 26
$1.3B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Stockholders' Equity
ENOV
ENOV
VRSN
VRSN
Q1 26
$1.5B
Q4 25
$2.0B
$-2.2B
Q3 25
$2.6B
$-2.1B
Q2 25
$2.6B
$-2.0B
Q1 25
$-2.0B
Q4 24
$2.6B
$-2.0B
Q3 24
$3.3B
$-1.9B
Q2 24
$3.3B
$-1.8B
Total Assets
ENOV
ENOV
VRSN
VRSN
Q1 26
$3.8B
Q4 25
$4.4B
$1.3B
Q3 25
$5.0B
$1.4B
Q2 25
$4.9B
$1.4B
Q1 25
$1.4B
Q4 24
$4.7B
$1.4B
Q3 24
$5.6B
$1.5B
Q2 24
$5.4B
$1.5B
Debt / Equity
ENOV
ENOV
VRSN
VRSN
Q1 26
0.90×
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
VRSN
VRSN
Operating Cash FlowLast quarter
$289.6M
Free Cash FlowOCF − Capex
$285.1M
FCF MarginFCF / Revenue
67.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
$82.6M
$289.6M
Q3 25
$47.8M
$307.7M
Q2 25
$-1.6M
$202.5M
Q1 25
$291.3M
Q4 24
$88.3M
$231.5M
Q3 24
$53.6M
$253.4M
Q2 24
$7.8M
$160.4M
Free Cash Flow
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
$29.1M
$285.1M
Q3 25
$3.4M
$303.0M
Q2 25
$-44.9M
$194.7M
Q1 25
$285.5M
Q4 24
$35.1M
$222.0M
Q3 24
$2.4M
$247.8M
Q2 24
$-31.6M
$151.2M
FCF Margin
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
5.3%
67.0%
Q3 25
0.6%
72.3%
Q2 25
-8.0%
47.5%
Q1 25
71.0%
Q4 24
6.3%
56.1%
Q3 24
0.5%
63.4%
Q2 24
-6.0%
39.1%
Capex Intensity
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
9.7%
1.1%
Q3 25
7.9%
1.1%
Q2 25
7.7%
1.9%
Q1 25
1.4%
Q4 24
9.5%
2.4%
Q3 24
10.1%
1.4%
Q2 24
7.5%
2.4%
Cash Conversion
ENOV
ENOV
VRSN
VRSN
Q1 26
Q4 25
1.40×
Q3 25
1.45×
Q2 25
0.98×
Q1 25
1.46×
Q4 24
1.21×
Q3 24
1.26×
Q2 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons